Breaking News Instant updates and real-time market news.

2018-09-18 10:46:44 FB Facebook $160.67 0.07 (0.04%) 10:46 09/18/18 09/18 10:46 09/18/18 10:46	Facebook named in job ad discrimination lawsuit, TechCrunch reports Facebook has been named in lawsuit alleging job ads on its platform unlawfully discriminated against women, TechCrunch reports. The legal action, filed on behalf of three female workers and backed by the American Civil Liberties Union, also names 10 employers who are alleged to have used Facebook's platform to "exclusively and unlawfully target job adverts" at male Facebook users, excluding women and non-binary users from receiving the ads. Reference Link	18 Sep 28 Oct
FB Facebook $160.67 0.07 (0.04%) 09/13/18 CLVD 09/13/18 NO CHANGE CLVD Facebook ad spend feedback turning more cautious, says Cleveland Research 09/13/18 CLVD 09/13/18 NO CHANGE CLVD Buy Cleveland Research lowers Facebook Q3 sales growth estimate Cleveland Research analyst Chandler Converse said feedback on near-term Facebook ad spending has turned more cautious as a result of changes to limit targeting and tracking in response to increased scrutiny and regulation. The targeting and tracking changes are viewed as driving lower ROI for some advertisers, leading to reduced budget allocation, while Facebook also appears to be seeing increased competitive pressure from Google (GOOGL) and Amazon (AMZN), Converse tells investors. The analyst lowered his Q3 sales growth forecast to about 33% from a prior view of 35%, though he maintains a Buy rating on Facebook shares. 09/14/18 PIPR 09/14/18 NO CHANGE PIPR Piper says Amazon, Facebook, Alphabet attractive despite regulatory pressure Piper Jaffray analyst Michael Olson believes shares of Amazon.com (AMZN), Facebook (FB) and Alphabet (GOOG, GOOGL) remain attractive despite increased regulatory pressure in the near-term. While current regulatory challenges present "multiple issues over the next few months," the long-term outlook remains favorable for all three companies, Olson tells investors in a research note. The analyst believes Facebook may be becoming less exposed from a regulatory perspective going forward given that the company "has now done extensive work to bring its platform in line with recent privacy regulations and because it is now giving the deserved attention to privacy." Between the three companies, Alphabet may face the most regulatory headwind given its open infrastructure marketing platform exposure on privacy and targeting, susceptibility to copyright changes through YouTube, and its dominant position in search amenable to antitrust issues, the analyst contends. However, he believes Google, YouTube, Android, and Gmail together "create a once-in-a-generation asset with continued strong revenue growth potential, high margins, and secular tailwinds." For Amazon, Olson sees the biggest worries as antitrust and Post Office changes. However, he thinks antitrust law precedent will be upheld and points out the company continues to build its own last-mile delivery to lessen its dependency on the United States Postal Service. 09/18/18 JPMS 09/18/18 NO CHANGE Target $195 JPMS Overweight JPMorgan cuts estimates for Facebook, drops price target to $195 JPMorgan analyst Doug Anmuth lowered his 2019 and 2020 earnings estimates for Facebook (FB) by 5%-6% on the company's bigger investment increases over the next couple years, which he does not believe are fully captured in consensus estimates. The analyst says Facebook remains the most controversial company in his Internet coverage universe. The company is in transition as it pushes Stories more prominently on the core platform and rolls out stronger privacy tools for users. Even with Facebook suggesting it could reach mid-30%'s operating margins in a few or several years, investments in 2019 could be larger than anticipated in consensus estimates, Anmuth tells investors in a research note. The analyst also cut his price target for the shares to $195 from $205. However, he keeps an Overweight rating on the shares. Anmuth's top overall Internet picks are Amazon.com (AMZN), Twitter (TWTR) and Yelp (YELP.)

2018-09-18 10:46:44

Facebook

$160.67: 0.07 (0.04%)

10:46

09/18/18

09/18

10:46

09/18/18

10:46

Facebook named in job ad discrimination lawsuit, TechCrunch reports

Facebook has been named in lawsuit alleging job ads on its platform unlawfully discriminated against women, TechCrunch reports. The legal action, filed on behalf of three female workers and backed by the American Civil Liberties Union, also names 10 employers who are alleged to have used Facebook's platform to "exclusively and unlawfully target job adverts" at male Facebook users, excluding women and non-binary users from receiving the ads. Reference Link

18
Sep
28
Oct

FB Facebook

$160.67: 0.07 (0.04%)

09/13/18: CLVD

09/13/18: CLVD

09/14/18: PIPR

09/18/18: JPMS

TODAY'S FREE FLY STORIES

AMZN Amazon.com $1,608.88 -13.47 (-0.83%) , XPO XPO Logistics $52.01 -7.535 (-12.65%) … 13:26 02/16/19 02/16 13:26 02/16/19 13:26 Periodicals	Amazon a risk for almost every stock/sector, Barron's says » Amazon (AMZN) is eating… AMZN Amazon.com $1,608.88 -13.47 (-0.83%) XPO XPO Logistics $52.01 -7.535 (-12.65%) KR Kroger $29.50 0.54 (1.86%) FAST Fastenal $62.97 0.61 (0.98%) GWW Grainger $316.63 4.9 (1.57%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Feb 20 Feb 20 Feb 20 Feb 03 Mar 18 Mar
YETI Yeti $22.85 0.97 (4.43%) 13:20 02/16/19 02/16 13:20 02/16/19 13:20 Periodicals	Yeti stock has 60% upside, Barron's says » Yeti Holdings stock… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
L Loews $46.67 0.785 (1.71%) 13:14 02/16/19 02/16 13:14 02/16/19 13:14 Periodicals	Investors can love Loews, Barron's says » Loews is a $15B… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Mar 28 May
EQIX Equinix $421.53 1.16 (0.28%) , COR CoreSite Realty $102.69 0.625 (0.61%) … 13:10 02/16/19 02/16 13:10 02/16/19 13:10 Periodicals	Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says » Data-center stocks may… EQIX Equinix $421.53 1.16 (0.28%) COR CoreSite Realty $102.69 0.625 (0.61%) IRM Iron Mountain $35.13 -0.14 (-0.40%) INXN Interxion $64.65 0.81 (1.27%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 26 Mar 26 Mar
NOK Nokia $6.31 0.015 (0.24%) , ERIC Ericsson $9.36 0.015 (0.16%) … 13:07 02/16/19 02/16 13:07 02/16/19 13:07 Periodicals	A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says » The next salvo in the… NOK Nokia $6.31 0.015 (0.24%) ERIC Ericsson $9.36 0.015 (0.16%) SSNLF Samsung $0.00 (0.00%) CSCO Cisco $49.45 1.05 (2.17%) JNPR Juniper $27.12 0.16 (0.59%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 26 Feb 27 Feb 28 Feb

COP ConocoPhillips $70.13 1.04 (1.51%) , MUR Murphy Oil $29.23 0.59 (2.06%) … 13:00 02/16/19 02/16 13:00 02/16/19 13:00 Periodicals	Dividend investors should look to oil stocks for big yields, Barron's says » Energy stocks aren't… COP ConocoPhillips $70.13 1.04 (1.51%) MUR Murphy Oil $29.23 0.59 (2.06%) CVX Chevron $119.30 1.19 (1.01%) VLO Valero $84.34 0.75 (0.90%) XOM Exxon Mobil $77.74 1.47 (1.93%) MRO Marathon Oil $17.07 0.15 (0.89%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	04 Mar 07 Mar 18 Mar 22 May 28 May
AMZN Amazon.com $1,608.88 -13.47 (-0.83%) 12:45 02/16/19 02/16 12:45 02/16/19 12:45 Periodicals	Protestors against NY's Amazon HQ2 got math wrong, Barron's says » On Thursday, Amazon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Feb 20 Feb 20 Feb 03 Mar 18 Mar
ICE IntercontinentalExchange $75.49 -0.46 (-0.61%) , NDAQ Nasdaq $87.74 0.56 (0.64%) … 12:28 02/16/19 02/16 12:28 02/16/19 12:28 Periodicals	Investors interested in U.S. cannabis companies face challenges, Barron's says » Investors interested in… ICE IntercontinentalExchange $75.49 -0.46 (-0.61%) NDAQ Nasdaq $87.74 0.56 (0.64%) CGC Canopy Growth $47.54 1.49 (3.24%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Feb 28 May 15 Feb
AMD AMD $23.68 0.55 (2.38%) , INTC Intel $51.64 0.85 (1.67%) … 08:43 02/16/19 02/16 08:43 02/16/19 08:43 On The Fly	Week in review: How Trump's policies moved stocks » Catch up on the top… Open Full Text AMD AMD $23.68 0.55 (2.38%) INTC Intel $51.64 0.85 (1.67%) MRVL Marvell $18.82 -0.37 (-1.93%) MCHP Microchip $91.10 0.49 (0.54%) MU Micron $41.99 -0.23 (-0.54%) NVDA Nvidia $157.22 2.69 (1.74%) QCOM Qualcomm $51.97 0.42 (0.81%) TXN Texas Instruments $107.55 0.57 (0.53%) TWTR Twitter $31.23 0.28 (0.90%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 21 Feb 25 Feb 07 Mar 07 Mar 25 Mar 26 Mar 28 May 04 Jun 05 Jun
AMGN Amgen $188.31 1.6 (0.86%) , ALPMY Astellas Pharma $0.00 (0.00%) … 04:55 02/16/19 02/16 04:55 02/16/19 04:55 Conference/Events	American Society of Clinical Oncology to hold a symposium » 2019 ASCO Genitourinary… AMGN Amgen $188.31 1.6 (0.86%) ALPMY Astellas Pharma $0.00 (0.00%) AZN AstraZeneca $40.92 0.93 (2.33%) BAYRY Bayer $0.00 (0.00%) BMY Bristol-Myers $51.64 0.81 (1.59%) CALA Calithera Biosciences $5.35 0.14 (2.69%) CLVS Clovis $25.44 (0.00%) DNA Bought by RHHBY $0.00 (0.00%) ESALY Eisai $0.00 (0.00%) EXEL Exelixis $22.26 -0.05 (-0.22%) IMMU Immunomedics $14.23 0.225 (1.61%) INO Inovio $3.70 0.01 (0.27%) MRK Merck $79.84 0.9 (1.14%) MYOV Myovant Sciences $21.48 0.1 (0.47%) MYGN Myriad Genetics $31.41 0.53 (1.72%) NH NantHealth $0.60 (0.00%) NVS Novartis $89.89 0.865 (0.97%) PFE Pfizer $42.41 0.45 (1.07%) PGNX Progenics $4.87 0.13 (2.74%) SGEN Seattle Genetics $71.48 2.92 (4.26%) SNY Sanofi $42.51 0.94 (2.26%) TYME Tyme Technologies $3.19 0.055 (1.76%) AVEO Aveo Pharmaceuticals $0.62 0.0092 (1.51%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Feb 16 Feb 19 Feb 20 Feb 25 Feb 26 Feb 26 Feb 28 Feb 07 Mar 11 Mar 22 Mar 11 Apr 28 Apr 18 May 20 May

WES Western Gas Partners $49.52 0.38 (0.77%) , WGP Western Gas Equity $32.38 0.2 (0.62%) 19:30 02/15/19 02/15 19:30 02/15/19 19:30 Recommendations	Western Gas Partners, Western Gas Equity analyst commentary at MUFG » MUFG raises price targets… MUFG raises price targets on Western Gas Partners to $55 from $50. MUFG analyst Barrett Blaschke raised his price target on Western Gas Partners (WES) to $55 with a Neutral rating and also lowered his price target on Western Gas Equity (WGP) to $42 from $45 with an Overweight rating ahead of the simplification combination of the two entities. The analyst notes that Western Gas experienced weather-related issues and operational challenges in Q4, and that without the accounting change adjustment, its EBITDA would have missed consensus. Blaschke maintains however that the simplification process under which Western Midstream Partners will be an IDR-free MLP and thus able to take advantage of the federal tax break of MLP status is the core focus for investors. WES Western Gas Partners $49.52 0.38 (0.77%) WGP Western Gas Equity $32.38 0.2 (0.62%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Feb 15 Feb 04 Mar
PXD Pioneer Natural $145.33 2.27 (1.59%) 19:19 02/15/19 02/15 19:19 02/15/19 19:19 Recommendations	Pioneer Natural analyst commentary at MUFG » Pioneer Natural price… Pioneer Natural price target lowed to $192 from $223 at MUFG. MUFG analyst Michael McAllister lowered his price target on Pioneer Natural to $192 after its Q4 EPS and EBITDA miss, with costs coming in 2% and exploration expense reported $10M higher than he expected. The analyst also lowers his FY20 production forecast to 13% vs. 18% prior forecast. McAllister keeps his Overweight rating on the stock, saying its implied enterprise value to EBITDA multiple of 8-times that is a premium to 6-times universe average is warranted "due to its top-tier acreage position, strength of its balance sheet, oil production growth and free cashflow potential". 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 May
ZTS Zoetis $95.38 2.16 (2.32%) 18:42 02/15/19 02/15 18:42 02/15/19 18:42 Hot Stocks	Zoetis CEO says: 'Diagnostics are more important in animals than humans' » In an interview on… In an interview on CNBC's Mad Money, Zoetis CEO Juan Ramon Alaix said: "Diagnostics are more important in animals than humans... We are doing very well in China... China is the third largest country for us... Apoquel is treating allergic reactions in dogs and it's doing very well." 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
JNJ Johnson & Johnson $136.40 2.13 (1.59%) 18:22 02/15/19 02/15 18:22 02/15/19 18:22 Hot Stocks	Johnson & Johnson CEO: 'We ended 2018 with great results' » In an interview on… In an interview on CNBC's Mad Money, Johnson & Johnson CEO Alex Gorsky said: "We ended 2018 with great results... We could not be more proud of Esketamine... One of the most exciting parts of my job is seeing technology being integrated with healthcare... Less than 5% of surgeries are performed by a robot, we think that can be greater." 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Feb 25 Feb 25 Feb 06 Mar
WIN Windstream $3.37 0.2 (6.31%) , UNIT Uniti Group $20.00 0.53 (2.72%) 18:18 02/15/19 02/15 18:18 02/15/19 18:18 Periodicals	Court says Windstream defaulted on bonds in 2015, Bloomberg says » A court has ruled that… A court has ruled that Windstream Holdings (WIN) defaulted on its bonds in 2015 by spinning off Uniti Group (UNIT), Bloomberg's Allison McNeely and Tiffany Kary report. The ruling in Manhattan federal court is a victory for Aurelius Capital, which argues taht the deal unfairly took assets away from bondholers that back up their investment, the reporters say. Windstream has warned that a loss could force it into bankruptcy, McNeely and Kary note. Reference Link WIN Windstream $3.37 0.2 (6.31%) UNIT Uniti Group $20.00 0.53 (2.72%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 28 Feb

BHVN Biohaven Pharmaceutical $45.32 1.36 (3.09%) 18:14 02/15/19 02/15 18:14 02/15/19 18:14 Hot Stocks	Biohaven treatment of multiple system atrophy granted FDA orphan designation » According to a post on… According to a post on the FDA's website, Biohaven Pharmaceutical's treatment of multiple system atrophy was granted orphan designation. Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AMGN Amgen $188.31 1.6 (0.86%) 18:11 02/15/19 02/15 18:11 02/15/19 18:11 Hot Stocks	Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation » According to a post on… According to a post on the FDA's website, Amgen's treatment of Acute Myeloid Leukemia was granted orphan designation. Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CE Celanese $100.19 1.19 (1.20%) 18:02 02/15/19 02/15 18:02 02/15/19 18:02 Hot Stocks	Celanese announces Acetyl Intermediates price increases in China » Celanese will increase… Celanese will increase list and off-list selling prices for the following acetyl intermediates products. The price increases are CNY550/MT for Acetic Acid, CNY300/MT for Vinyl Acetate Monomer, CNY575/MT for Acetic Anhydride, and CNY100/MT for Vinyl Acetate-based Emulsions. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WIN Windstream $3.37 0.2 (6.31%) , UNIT Uniti Group $20.00 0.53 (2.72%) 17:58 02/15/19 02/15 17:58 02/15/19 17:58 Periodicals	Court says Windstream defaulted on bonds in 2015, Bloomberg says » A court has ruled that… A court has ruled that Windstream Holdings (WIN) defaulted on its bonds in 2015 by spinning off Uniti Group (UNIT), Bloomberg reports. The ruling in Manhattan federal court is a victory for Aurelius Capital, which argues taht the deal unfairly took assets away from bondholers that back up their investment, the report says. WIN Windstream $3.37 0.2 (6.31%) UNIT Uniti Group $20.00 0.53 (2.72%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 28 Feb
GLD SPDR Gold Shares $124.81 0.77 (0.62%) 17:41 02/15/19 02/15 17:41 02/15/19 17:41 Hot Stocks	SPDR Gold Shares holdings fall to 793.03MT from 796.85MT » This is the lowest level… This is the lowest level of holdings since December 31, 2018. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

MDLZ Mondelez $48.17 0.84 (1.77%) 17:26 02/15/19 02/15 17:26 02/15/19 17:26 Hot Stocks	Mondelez to transfer listing of debt securities to Nasdaq » Mondelez International,… Mondelez International, Inc. announced its intention to transfer the securities exchange listing for its notes listed below from the New York Stock Exchange to the Nasdaq Bond Exchange effective February 25, 2019 after market close. The debt securities are expected to begin trading on the Nasdaq Bond Exchange on February 26, 2019. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Feb 06 Mar 28 May
FN Fabrinet $55.23 0.67 (1.23%) 17:25 02/15/19 02/15 17:25 02/15/19 17:25 Hot Stocks	Fabrinet CFO sells 20K shares of common stock » In a regulatory filing,… In a regulatory filing, Fabrinet CFO Toh-Seng Ng disclosed a February 14th-15th sale of 20K shares of common stock at an average price of $54.73 per share. The total transaction size was $1.09M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Feb 27 Feb 28 Feb 04 Mar
UBER Uber $0.00 (0.00%) 17:24 02/15/19 02/15 17:24 02/15/19 17:24 Periodicals	Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says » Uber is suing New York… Uber is suing New York City over a government decision to limit the number of ride-hailing drivers allowed on the streets, Bloomberg's Eric Newcomer reports. Officials partly justified such caps on for-hire drivers as a way to cut down on congestion, Newcomer notes. In the lawsuit, Uber contends that the city doesn't have the evidence to prove that claim and alleges that Mayor Bill de Blasio is treating the business unfairly, the author says. Reference Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $277.40 2.93 (1.07%) 17:19 02/15/19 02/15 17:19 02/15/19 17:19 Periodicals	House Democrats to probe POTUS emergency declaration, Bloomberg says » The House Judiciary… The House Judiciary Committee intends to investigate the "serious constitutional and statutory issues" raised by U.S. President Donald Trump's declaration of emergency on the southern border, Bloomberg's Billy House reports. The committee, led by Democrat Jerrold Nadler, asked the White Hose to make available for a hearing administration employees involved in the declaration that redirects roughly $7B in the federal budget to build a wall on the U.S.-Mexico border, House says. Reference Link SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $277.40 2.93 (1.07%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ORCL Oracle $51.71 0.25 (0.49%) 17:11 02/15/19 02/15 17:11 02/15/19 17:11 Hot Stocks	Oracle authorizes additional $12B stock buyback under existing program » In a regulatory 8K… In a regulatory 8K filing, Oracle states that on February 12th, its board authorized the repurchase of up to an additional $12.0 billion of common stock under an existing share repurchase program. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as Oracle's working capital needs, cash requirements for acquisitions and dividend payments, debt repayment obligations or repurchases of Oracle's debt, Oracle's stock price, and economic and market conditions. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Mar 06 Mar

Events

Earnings calls, analyst events, roadshows and more

Tomorrow at 00:00

Toy Fair 2019 Conferences

Jacob K. Javits Center, New York, NY
HOLI
Tomorrow at 20:00

Hollysys - HOLI Conference Calls
ALXN
2019-02-18 at 00:00

PDUFA Date for AALXN1210 Government Event
2019-02-18 at 00:00

Toy Fair 2019 Conferences

Jacob K. Javits Center, New York, NY
2019-02-18 at 00:00

Taiwan CEO-CFO Conference Conferences

Taipei
GIS ...
2019-02-18 at 00:00

CAGNY Conference 2019 Conferences

New York, NY
DDAIF
2019-02-18 at 00:00

Daimler AG Firm Sponsored Meetings

New York, NY
2019-02-18 at 03:00

Economics & Strategy--Asia Industry Meetings
CUB
2019-02-18 at 14:30

Cubic Firm Sponsored Meetings

Co Offices--9333 Balboa Avenue, San Diego, CA
2019-02-19 at 00:00

Taiwan CEO-CFO Conference Conferences

Taipei

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	ANCN X ANCN Anchiano Therapeutics IPO Managers: Oppenheimer, Ladenburg Priced at: $11.50 2.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MITT X MITT AG Mortgage Spot Secondary Managers: Morgan Stanley, JMP Securities Priced at: $17.05 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NMFC X NMFC New Mountain Finance Spot Secondary Managers: Wells Fargo, Morgan Stanley, Goldman Sachs & Keefe Bruyette, Janney Montgomery Scott, Oppenheimer Priced at: $13.57 3.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PMT X PMT PennyMac Mortgage Spot Secondary Managers: Credit Suisse, BofA/Merrill, Deutsche Bank, Morgan Stanley & Goldman Sachs Priced at: $20.64 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	G X G Genpact Block Trade Managers: Goldman Sachs Priced at: $32.40 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GLIBA X GLIBA GCI Liberty Block Trade Managers: UBS Priced at: $51.60 1.47M Shares MGNX X MGNX MacroGenics Spot Secondary Managers: SVB Leerink & Evercore ISI Priced at: $20.00 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	HUBS X HUBS HubSpot Block Trade Managers: Morgan Stanley Priced at: $165.00 1.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYOK X MYOK MyoKardia Block Trade Managers: Morgan Stanley Priced at: $39.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AVDR X AVDR Avedro IPO Managers: BofA/Merrill & JPMorgan, Cowen, Guggenheim, SVB Leerink Priced at: $14.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics IPO Managers: Jefferies, SVB Leerink & BMO Capital, Wedbush, China Renaissance Priced at: $15.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XERS X XERS Xeris Pharmaceuticals Secondary Managers: Jefferies, SVB Leerink, RBC Capital & MIZU Priced at: $10.00 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ICE X ICE IntercontinentalExchange Block Trade Managers: Morgan Stanley Priced at: $75.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MITO X MITO Stealth Biotherapeutics IPO Managers: Jefferies, Evercore ISI & BMO Capital, Nomura Instinet Priced at: $12.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKAO X AKAO Achaogen Spot Secondary Managers: H.C. Wainwright Priced at: $1.00 15M Shares REED X REED Reed's Spot Secondary Managers: Roth Capital Priced at: $2.10 6.725M Shares
Fri	No deals

Mon	No deals
Tues	VTUS X VTUS Virgin Trains IPO Managers: Barclays, JPMorgan & Morgan Stanley, BofA/Merrill, Allen & Co., JMP Securities, Raymond James $17.00-19.00 28.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	CBUS X CBUS Cibus IPO Managers: Morgan Stanley & BofA/Merrill, Piper Jaffray, BMO Capital $14.00-16.00 6.667M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Facebook named in job ad discrimination lawsuit, TechCrunch reports

TODAY'S FREE FLY STORIES

Get Full Fly Access